Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process (Q38880125)

7 September 2017

title

Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process (English)

1 reference

7 September 2017

main subject

Orthoebolavirus zairense

0 references

1 reference

9

Giorgio Palù

1 reference

7 September 2017

4

Arianna Calistri

1 reference

7 September 2017

8

Cristina Parolin

1 reference

7 September 2017

Cristiano Salata

1

1 reference

7 September 2017

Aldo Baritussio

2

1 reference

7 September 2017

Denis Munegato

3

1 reference

7 September 2017

Huy Riem Ha

5

1 reference

7 September 2017

Laurent Bigler

6

1 reference

7 September 2017

Fabrizio Fabris

7

1 reference

7 September 2017

Ali Mirazimi

10

1 reference

7 September 2017

publication date

30 April 2015

1 reference

7 September 2017

published in

Pathogens and disease

1 reference

7 September 2017

volume

73

1 reference

7 September 2017

issue

5

1 reference

Identification of a small-molecule entry inhibitor for filoviruses

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Amiodarone inhibits arterial thrombus formation and tissue factor translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Effect of amiodarone on membrane fluidity and Na+/K+ ATPase activity in rat-brain synaptic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

21 January 2018

Ebola haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Identification and quantitation of novel metabolites of amiodarone in plasma of treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Lysosomal degradation of membrane lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Ebolavirus glycoprotein structure and mechanism of entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Ebola virus entry requires the host-programmed recognition of an intracellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Bepridil and amiodarone simultaneously target the Alzheimer's disease beta- and gamma-secretase via distinct mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV032

Synthesis and cytotoxicity properties of amiodarone analogues

21 January 2018

1 reference

12 December 2020

Small molecule inhibitors of ebola virus infection

1 reference

12 December 2020

Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype

1 reference

12 December 2020

FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.

1 reference

12 December 2020

Amiodarone inhibits lung degradation of SP-A and perturbs the distribution of lysosomal enzymes

1 reference

12 December 2020

Identifiers

DOI

10.1093/FEMSPD/FTV032

1 reference

7 September 2017

1 reference